Arkolith/Insider Trading/SNTI/Form 4

Rajangam Kanya

Pres. & Chief Med. & Dev. Off.Senti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Conversion(C)33K$2.25$74K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Conversion(C)33$2250.00$74K0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-25-000034) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML